Sort
39,280 grants matching “leukemia”
Clinical Trials Evaluating Transplant Strategies and Adoptive Cell Therapies to
$400,570Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2017 · CA
MOLECULAR MECHANISMS OF NUCLEIC ACID DAMAGE BY ENEDIYNES
$400,552Harvard University (Medical School) · R01 · FY2003 · GM
MOLECULAR BIOLOGY OF HUMAN MYELOID DIFFERENTIATION
$400,491Beth Israel Deaconess Medical Center · R01 · FY2002 · CA
SOLID STATE RADIATION CHEMISTRY OF DNA
$400,489University Of Rochester · R01 · FY2002 · CA
Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML
$400,445Jian Huang · Coriell Institute For Medical Research · R01 · FY2023 · CA
Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML
$400,445Jian Huang · Coriell Institute For Medical Research · R01 · FY2022 · CA
Occupational Exposure Assessment
$400,216Melissa Friesen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA
Co-targeting S6 and TAM kinases in PTEN-deficient glioblastoma
$400,209David R Plas · University Of Cincinnati · R01 · FY2024 · CA
Physiologic Regulation of Hematopoiesis by Notch
$400,188Nadia Carlesso · Indiana University Indianapolis · R01 · FY2015 · DK
Nuclear Receptor Functional Profiling in Metabolism and Disease
$400,172Ronald M. Evans · Baylor College Of Medicine · U19 · FY2009 · DK
Nuclear Receptor Functional Profiling in Metabolism and Disease
$400,172Ronald M. Evans · Baylor College Of Medicine · U19 · FY2008 · DK
Nuclear Receptor Functional Profiling in Metabolism and Disease
$400,171Ronald M. Evans · Baylor College Of Medicine · U19 · FY2010 · DK
Understanding the role of histone 3 lysine 4 trimethylation in neonatal innate immune development under normal and inflammatory conditions
$400,162Jennifer Bermick · University Of Michigan At Ann Arbor · R01 · FY2020 · AI
Community Clinical Oncology Program
$400,119Northshore Univ Healthsystem Res Inst · U10 · FY2004 · CA
Tissue-specific tumor suppressor effects of p53
$400,089James J. Manfredi · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · CA
Validating a novel biomarker of clinical progression and survival in CLL
$400,042Randall S Davis · University Of Alabama At Birmingham · R33 · FY2012 · CA
Function and Biology of Eukaryotic DNA Topoisomerases
$400,040Neil Osheroff · Vanderbilt University · R01 · FY2015 · GM
Targeting AML Mitochondria by Ceramide
$400,000Besim Ogretmen · Lipo-Immuno Tech, Llc · R41 · FY2022 · CA
Immune privilege of the hematopoieitic stem cell niche
$400,000Joji Fujisaki · Columbia University Health Sciences · R01 · FY2016 · HL
Gene and Cytokine Expression in Tolerance and GVHD
$400,000Samuel Strober · Stanford University · R01 · FY2009 · AI
Yes1 as a quiescence regulator in hematopoietic stem cells
$400,000Siddhartha Mukherjee · Columbia University Health Sciences · R01 · FY2017 · HL
Immune privilege of the hematopoieitic stem cell niche
$400,000Joji Fujisaki · Columbia University Health Sciences · R01 · FY2017 · HL
Engineering in vivo half-life extension of a novel mammalian asparaginase to increase feasibility of pan-cancer therapy
$400,000Amanda M Schalk · Enzyme By Design, Inc. · R43 · FY2024 · CA
A Dose Expansion Study of SX-682 Alone and in Combination with Decitabine in MDS Patients
$400,000Aaron D Schuler · Syntrix Biosystems, Inc. · R44 · FY2024 · CA
CAREER: Advancing Model Predictive Control of Cell Differentiation
$400,000Ann Rundell · Purdue University · · FY2009 · ENG